| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 11 | 2020 | 430 | 3.580 |
Why?
|
| Tumor Microenvironment | 12 | 2020 | 580 | 2.960 |
Why?
|
| Breast Neoplasms | 27 | 2020 | 2542 | 2.470 |
Why?
|
| Neoplasm Metastasis | 22 | 2020 | 711 | 2.410 |
Why?
|
| RNA Splicing | 10 | 2021 | 232 | 1.420 |
Why?
|
| Neoplasms | 8 | 2020 | 2807 | 1.360 |
Why?
|
| Myeloid-Derived Suppressor Cells | 5 | 2020 | 51 | 1.350 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 558 | 1.330 |
Why?
|
| Stem Cell Niche | 3 | 2020 | 57 | 1.320 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2019 | 219 | 1.230 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2021 | 242 | 1.110 |
Why?
|
| Benzamides | 2 | 2018 | 114 | 1.110 |
Why?
|
| Exons | 10 | 2009 | 808 | 1.050 |
Why?
|
| Osteogenesis | 2 | 2018 | 156 | 0.990 |
Why?
|
| Pyrazoles | 2 | 2018 | 313 | 0.950 |
Why?
|
| RNA Splice Sites | 7 | 2009 | 94 | 0.950 |
Why?
|
| Macrophages | 5 | 2020 | 642 | 0.940 |
Why?
|
| Neutrophils | 3 | 2020 | 383 | 0.870 |
Why?
|
| Myeloid Cells | 3 | 2019 | 104 | 0.780 |
Why?
|
| Bone Marrow | 4 | 2017 | 326 | 0.770 |
Why?
|
| Cell Line, Tumor | 23 | 2021 | 3449 | 0.720 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.700 |
Why?
|
| Methylmalonic Acid | 1 | 2020 | 15 | 0.700 |
Why?
|
| Animals | 48 | 2021 | 34533 | 0.670 |
Why?
|
| Iliac Artery | 2 | 2016 | 80 | 0.630 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 467 | 0.630 |
Why?
|
| Introns | 7 | 2021 | 302 | 0.620 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 3 | 2009 | 16 | 0.610 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 219 | 0.610 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1725 | 0.590 |
Why?
|
| Bone and Bones | 2 | 2017 | 271 | 0.580 |
Why?
|
| Signal Transduction | 17 | 2021 | 4638 | 0.570 |
Why?
|
| Aurora Kinases | 1 | 2017 | 26 | 0.550 |
Why?
|
| Immunotherapy | 2 | 2019 | 685 | 0.540 |
Why?
|
| RNA Precursors | 4 | 2015 | 64 | 0.530 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 438 | 0.520 |
Why?
|
| Mice | 34 | 2021 | 17881 | 0.510 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 265 | 0.500 |
Why?
|
| Disease Progression | 8 | 2020 | 2103 | 0.500 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 239 | 0.490 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 745 | 0.480 |
Why?
|
| Cell Separation | 1 | 2015 | 229 | 0.470 |
Why?
|
| Interleukin-17 | 1 | 2015 | 122 | 0.470 |
Why?
|
| Specimen Handling | 1 | 2015 | 142 | 0.470 |
Why?
|
| Humans | 62 | 2021 | 126330 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 625 | 0.450 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2013 | 285 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 475 | 0.440 |
Why?
|
| Mice, Nude | 8 | 2020 | 723 | 0.420 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 698 | 0.380 |
Why?
|
| Alternative Splicing | 4 | 2008 | 357 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 1987 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 1006 | 0.360 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 796 | 0.360 |
Why?
|
| Female | 36 | 2021 | 67333 | 0.350 |
Why?
|
| Brain Neoplasms | 5 | 2021 | 1324 | 0.330 |
Why?
|
| Computational Biology | 2 | 2005 | 838 | 0.330 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 6 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 4467 | 0.320 |
Why?
|
| Lung Neoplasms | 9 | 2020 | 1668 | 0.310 |
Why?
|
| ErbB Receptors | 4 | 2020 | 287 | 0.310 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 224 | 0.310 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 921 | 0.300 |
Why?
|
| RNA, Messenger | 5 | 2018 | 2818 | 0.300 |
Why?
|
| Spliceosomes | 2 | 2021 | 55 | 0.290 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2015 | 74 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4466 | 0.280 |
Why?
|
| Cell Movement | 4 | 2018 | 856 | 0.270 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 454 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 67 | 0.260 |
Why?
|
| Evolution, Molecular | 2 | 2008 | 670 | 0.260 |
Why?
|
| Vertebrates | 1 | 2006 | 39 | 0.260 |
Why?
|
| Cell Survival | 5 | 2021 | 835 | 0.260 |
Why?
|
| Models, Genetic | 3 | 2017 | 764 | 0.260 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 546 | 0.230 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 195 | 0.230 |
Why?
|
| Receptor, ErbB-2 | 3 | 2018 | 519 | 0.220 |
Why?
|
| Codon, Terminator | 1 | 2004 | 25 | 0.220 |
Why?
|
| Artificial Intelligence | 2 | 2005 | 250 | 0.220 |
Why?
|
| Genome | 1 | 2006 | 482 | 0.210 |
Why?
|
| Cell Proliferation | 6 | 2020 | 2394 | 0.210 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 58 | 0.200 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 131 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2020 | 364 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2019 | 888 | 0.190 |
Why?
|
| Statistics as Topic | 2 | 2017 | 257 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 495 | 0.190 |
Why?
|
| Chemokine CXCL12 | 2 | 2013 | 38 | 0.190 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 1716 | 0.180 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1291 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 2549 | 0.180 |
Why?
|
| Neoplasm Transplantation | 4 | 2021 | 387 | 0.180 |
Why?
|
| Calcium | 3 | 2018 | 1111 | 0.180 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 415 | 0.180 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 11 | 0.180 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 108 | 0.170 |
Why?
|
| Mice, SCID | 6 | 2021 | 595 | 0.170 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 21 | 0.170 |
Why?
|
| Cadherins | 3 | 2018 | 174 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 56 | 0.170 |
Why?
|
| Carcinoma | 2 | 2020 | 290 | 0.170 |
Why?
|
| RNA Interference | 3 | 2018 | 512 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 42 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2020 | 2618 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 194 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 1171 | 0.160 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 1551 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2020 | 348 | 0.160 |
Why?
|
| Granulocytes | 1 | 2019 | 67 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 218 | 0.160 |
Why?
|
| U937 Cells | 1 | 2018 | 24 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2018 | 29 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 42 | 0.150 |
Why?
|
| 3T3 Cells | 1 | 2018 | 119 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2005 | 298 | 0.150 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3901 | 0.150 |
Why?
|
| Everolimus | 1 | 2018 | 49 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2017 | 243 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 103 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 129 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 362 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 356 | 0.140 |
Why?
|
| Genomics | 3 | 2021 | 1538 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 1280 | 0.140 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 164 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 564 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 260 | 0.140 |
Why?
|
| Wnt Proteins | 3 | 2013 | 217 | 0.140 |
Why?
|
| Pericytes | 1 | 2017 | 21 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 625 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 67 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 102 | 0.130 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 60 | 0.130 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 38 | 0.130 |
Why?
|
| Morpholines | 1 | 2017 | 60 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2017 | 75 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2018 | 246 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2016 | 868 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2015 | 305 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2018 | 874 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3777 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 100 | 0.130 |
Why?
|
| Hindlimb | 1 | 2016 | 82 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 124 | 0.130 |
Why?
|
| Base Sequence | 4 | 2021 | 3118 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 274 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 569 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2017 | 153 | 0.130 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 127 | 0.130 |
Why?
|
| Pyridones | 1 | 2017 | 119 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 483 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 66 | 0.130 |
Why?
|
| Injections, Intra-Arterial | 1 | 2015 | 17 | 0.130 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 449 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 235 | 0.120 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 91 | 0.120 |
Why?
|
| Tenascin | 2 | 2015 | 31 | 0.120 |
Why?
|
| Smad Proteins | 2 | 2015 | 42 | 0.120 |
Why?
|
| Femur | 1 | 2015 | 68 | 0.120 |
Why?
|
| Mitochondria | 1 | 2020 | 696 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 86 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 328 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2015 | 63 | 0.120 |
Why?
|
| Tibia | 1 | 2015 | 72 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 105 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2017 | 508 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 666 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 55 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2017 | 511 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 4742 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 260 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 150 | 0.110 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 211 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 115 | 0.110 |
Why?
|
| Fibrinolysin | 1 | 2014 | 12 | 0.110 |
Why?
|
| Models, Biological | 2 | 2017 | 1469 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 131 | 0.110 |
Why?
|
| Serpins | 1 | 2014 | 27 | 0.110 |
Why?
|
| Carcinogenesis | 2 | 2014 | 345 | 0.110 |
Why?
|
| Prostate | 1 | 2016 | 433 | 0.110 |
Why?
|
| Glucose | 1 | 2018 | 881 | 0.110 |
Why?
|
| Mutation | 5 | 2020 | 5965 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2014 | 113 | 0.100 |
Why?
|
| Aging | 1 | 2020 | 1208 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2013 | 93 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 1560 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1722 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 126 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 891 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 343 | 0.090 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 75 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 122 | 0.090 |
Why?
|
| Apoptosis | 4 | 2021 | 1839 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 165 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 747 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 476 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 423 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 560 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 833 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 1789 | 0.080 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2009 | 13 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6645 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2018 | 1640 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 93 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 64 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2008 | 107 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2011 | 621 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 1064 | 0.080 |
Why?
|
| Cricetinae | 1 | 2009 | 397 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2017 | 664 | 0.070 |
Why?
|
| Histones | 1 | 2011 | 536 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 1342 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 307 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2007 | 63 | 0.070 |
Why?
|
| Gene Amplification | 2 | 2021 | 236 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2008 | 157 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2015 | 389 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 212 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 581 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2006 | 79 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 375 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 36 | 0.070 |
Why?
|
| Alu Elements | 1 | 2006 | 65 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 1029 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2007 | 238 | 0.060 |
Why?
|
| Transfection | 2 | 2007 | 1073 | 0.060 |
Why?
|
| Genetic Code | 1 | 2005 | 40 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 718 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 393 | 0.060 |
Why?
|
| Genome, Insect | 1 | 2006 | 99 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 552 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 379 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 161 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2428 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 19962 | 0.060 |
Why?
|
| RNA, Double-Stranded | 2 | 2021 | 64 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 318 | 0.060 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2004 | 6 | 0.060 |
Why?
|
| Brain | 2 | 2014 | 3034 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1325 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 62 | 0.060 |
Why?
|
| Chromatin | 1 | 2007 | 578 | 0.060 |
Why?
|
| Untranslated Regions | 1 | 2003 | 8 | 0.050 |
Why?
|
| Base Composition | 1 | 2003 | 69 | 0.050 |
Why?
|
| Cell Line | 2 | 2007 | 2734 | 0.050 |
Why?
|
| Cytosine | 1 | 2003 | 57 | 0.050 |
Why?
|
| Guanine | 1 | 2003 | 61 | 0.050 |
Why?
|
| Genes | 1 | 2004 | 446 | 0.050 |
Why?
|
| Mammals | 1 | 2004 | 257 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 942 | 0.050 |
Why?
|
| Receptors, Notch | 2 | 2016 | 206 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 578 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1597 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1685 | 0.050 |
Why?
|
| Lung | 1 | 2009 | 1508 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2003 | 477 | 0.040 |
Why?
|
| Software | 1 | 2005 | 698 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 67 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 796 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 789 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 102 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 76 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 592 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 90 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 180 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 126 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 296 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 194 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 103 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 131 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 137 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 137 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 84 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Phospholipid Ethers | 1 | 2018 | 7 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2018 | 7 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 42 | 0.040 |
Why?
|
| Estradiol | 1 | 2020 | 528 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3040 | 0.040 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2018 | 22 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 34 | 0.040 |
Why?
|
| Estrogens | 1 | 2020 | 504 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 241 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 34 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 212 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 65 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 116 | 0.040 |
Why?
|
| Ribosomes | 1 | 2018 | 135 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 154 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2689 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 673 | 0.030 |
Why?
|
| Proteomics | 1 | 2021 | 513 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1517 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 172 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2017 | 246 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 457 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2011 | 797 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 746 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 343 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 11 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 611 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 4323 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 72 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 53 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 51 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 65 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 98 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 174 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1038 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 181 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 319 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 21 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 32 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 364 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 171 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 423 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 196 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1931 | 0.030 |
Why?
|
| Male | 4 | 2020 | 62031 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2012 | 13 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2012 | 44 | 0.030 |
Why?
|
| Goosecoid Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 106 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 31 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 913 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3153 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 566 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 257 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2070 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 89 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 354 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 219 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 348 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1647 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2194 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 654 | 0.020 |
Why?
|
| Leukocytes | 1 | 2011 | 213 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 275 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2594 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2009 | 6 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 18 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2009 | 14 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 1400 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 298 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 146 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1081 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 427 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 144 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 25 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2008 | 70 | 0.020 |
Why?
|
| Macaca | 1 | 2008 | 61 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2719 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 218 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 214 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2006 | 22 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 286 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 677 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 685 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3622 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2011 | 1073 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1399 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 771 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 859 | 0.010 |
Why?
|
| Genome, Human | 1 | 2007 | 1304 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 730 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16517 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12380 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 27031 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 29802 | 0.010 |
Why?
|